OflarEAkdenizEYıldızC, et al.Evaluation of systemic immune-inflammation index for predicting severity of lower extremity arterial disease. Vascular2024; 17085381241251772. DOI:10.1177/17085381241251772.
2.
CiumanghelIBuzincuICiumanghelAI, et al.Epidemiology, clinical features and prognostic factors in patients with Covid-19 and acute limb ischaemia - a single center study. Vascular2024; 17085381241236932. DOI:10.1177/17085381241236932.
3.
NanaPDakisKSpanosK, et al.COVID-19 related peripheral arterial thrombotic events in intensive care unit and non-intensive care unit patients: a retrospective case series. Vascular2024; 32: 366–373. DOI: 10.1177/17085381221140159.
4.
TanzadehpanahHLotfianEAvanA, et al.Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases. Biomed Pharmacother2023; 166: 115321.
5.
JaffMRWhiteCJHiattWR, et al.An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society Consensus for the management of peripheral arterial disease (TASC II). J Endovasc Ther2015; 22(5): 663–677.
6.
EnginMGüvençO. Investigation of the predictive values of triglyceride/HDL cholesterol ratio and whole blood viscosity with regard to severe peripheral or carotid artery disease in patients scheduled for coronary bypass. Heart Surg Forum2020; 23(3): E310–E314.
7.
AydınUEnginMKatNK, et al.Investigation of the effects of diabetes mellitus on left internal thoracic artery flow patterns in patients scheduled to undergo coronary bypass graft surgery. J Clin Ultrasound2022; 50(6): 789–794.
